A Study Evaluating Targeted Therapies in Participants Who Have Advanced Solid Tumors With Genomic Alterations or Protein Expression Patterns Predictive of Response
Clinical trial NCT04632992 · COMPLETED
Trial details
- NCT number
- NCT04632992
- Sponsor
- Genentech, Inc.
- Status
- COMPLETED
- Phase
- Phase 2
- Study type
- INTERVENTIONAL
- Start date
- 2021-01-13
- Primary completion
- 2023-12-04
- Enrollment
- 252
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.